BW 1370U87

Drug Profile

BW 1370U87

Alternative Names: 1370U; BW-1370U87

Latest Information Update: 05 Jan 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Developer GlaxoSmithKline; Krenitsky Pharmaceuticals
  • Class Antidepressants; Small molecules
  • Mechanism of Action Monoamine oxidase A inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Anxiety disorders; Major depressive disorder

Most Recent Events

  • 20 Sep 2000 No-Development-Reported for Anxiety disorders in USA (Unknown route)
  • 19 Jun 1997 Krenitsky Pharmaceuticals is developing BW 1370U87 for Anxiety Disorders
  • 19 Jun 1997 Phase-I clinical trials for Anxiety disorders in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top